Today's Wall Street Journal reports on the sector that is handing some big losses to value funds: financials.
Companies like Merrill Lynch & Co., Inc. (NYSE: MER) and Citigroup Inc. (NYSE: C) have seen their stocks tank in the wake of the subprime meltdown, and value investors who have liked the low P/Es and attractive yields are holding the bag.
The Journal reports that "The average large-cap value fund is down 2.6% so far this year, according to Morningstar Inc. But that average disguises double-digit losses at a number of well-regarded value funds. Among them, Touchstone Large Cap Value Fund is down 32% and the Hotchkis & Wiley Core Value Fund has lost 15.1%. Investors in Weitz Value, run by veteran value manager Wally Weitz, are down 14.2%. That contrasts with a 0.9% increase in the Standard & Poor's 500-stock index (including dividends) and an 8.2% gain in the average large-cap growth fund."
I consider myself a value investors but the beating that they've taken on some of these stocks underscores one of the pitfalls in the regimens of many investors: over-reliance on ratios and cash flow analysis, without really understanding the fundamentals that drive a company and its industry. A lot of very smart people were predicting subprime trouble, and some had the foresight to short these financial stocks -- but it appears that some mutual funds were blinded by low P/Es and high ROE's.
But in the end, those are just helpful tools for understanding business fundamentals, something many investors ultimately ignored.
Last updated: February 13, 2012: 01:30 PM
Hot Stocks
DailyFinance Headlines
- 3 Keys to a Great Balance Transfer Card (and 1 Card That Offers Them)
- Is It Already 'The End' for E-Book Readers?
- Retail Stocks Are for Suckers: Why Their Rally Won't Last
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
Benzinga Headlines
- Airlines the Latest to Suffer Euro Crisis Blues
- Internet-Hungry Consumers Force Vodafone to Consider a C&W Offer
- Seven Japanese Stocks Up More Than 10% Year to Date
- Does the 2012 Election Really Matter for the Economy?
- Michigan Consumer Sentiment Index Drops
TheFlyOnTheWall.com Headlines
- European Commission approves acquisition of Motorola Mobility by Google
- Blue Coat Systems shareholders approve merger with Thoma Bravo
- Google confirms services blocked in Iran, Bloomberg reports
- NYSE market internals summary
- Google's proposed acquisition of Motorola Mobility cleared by EU, Bloomberg says
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 3 Keys to a Great Balance Transfer Card (and 1 Card That Offers Them)
- Is It Already 'The End' for E-Book Readers?
- Retail Stocks Are for Suckers: Why Their Rally Won't Last
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
5-Hour Energy: A Success Equal Parts Caffeine, Chemistry and…
How State Taxes Put a Bigger Pinch on the Poor


Reader Comments (Page 1 of 1)
11-28-2007 @ 11:23PM
Brockage said...
The lack of foresight by many investors is a disease that runs rampant -- water shortages, carbon dioxide releases, and countless othe problems just seem to sit with not much alarm from the governing class. Oh, they talk; they're good at that, but action?--nah.